Skip to main content
SpringerLink
Log in

Does bisphosphonate-based anti-osteoporosis medication affect osteoporotic spinal fracture healing?

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

Effects of bisphosphonate on fracture healing were prospectively investigated for osteoporotic spinal fracture. Although there were no significant differences in clinical outcomes, the presence of intravertebral cleft was related to the medication use. These results suggest that suspension of bisphosphonate use should be considered during the fracture healing period.

Introduction

The purpose of this prospective study is to investigate whether bisphosphonate-based anti-osteoporosis medication affects fracture healing and clinical outcomes of conservatively treated osteoporotic spinal fractures (OSFs).

Methods

A total of 105 patients who were diagnosed with acute OSFs were prospectively enrolled. According to their previous medication history, the patients were allocated into group I (n = 39, no history of bisphosphonate use) or group II (n = 66, history of bisphosphonate use). Clinical outcomes were assessed using visual analogue scale (VAS), and Oswestry disability index (ODI). Radiographic parameters including changes in height loss and kyphotic angle at the index vertebra were measured, and radiographic findings suggesting impaired fracture healing such as the intravertebral cleft (IVC) sign and fracture instability were evaluated. Univariate and multivariate regression analyses were used to identify related factors.

Results

There were no significant differences in the last VAS and ODI between groups. There were also no significant differences in the radiographic parameters. Although the IVC sign was seen more commonly in group II (30.3 %) than in group I (20.5 %), fracture instability combined with IVC was noted in the same number of cases. On multiple regression analysis, medication history showed no significant relationship with the clinical parameters. However, the presence of the IVC sign was related to medication history (odds ratio 4.8; 95 % confidence interval [CI] 1.02–22.69).

Conclusions

Bisphosphonate use does not significantly affect the clinical results during conservative treatment for OSFs. However, the occurrence of the IVC sign was related to medication history. Although further studies are needed to verify our findings, these results suggest that suspension of bisphosphonate use should be considered during the fracture healing period for acute OSFs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22:465–475

    Article  PubMed  Google Scholar 

  2. Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726–1733

    Article  CAS  PubMed  Google Scholar 

  3. Silverman SL, Watts NB, Delmas PD, Lange JL, Lindsay R (2007) Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study. Osteoporos Int 18:25–34

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Siris ES, Harris ST, Eastell R, Zanchetta JR, Goemaere S, Diez-Perez A, Stock JL, Song J, Qu Y, Kulkarni PM, Siddhanti SR, Wong M, Cummings SR, Continuing Outcomes Relevant to Evista (CORE) investigators (2005) Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study. J Bone Miner Res 20:1514–1524

    Article  CAS  PubMed  Google Scholar 

  5. Bruyere O, Detilleux J, Chines A, Reginster JY (2012) Relationships between changes in bone mineral density or bone turnover markers and vertebral fracture incidence in patients treated with bazedoxifene. Calcif Tissue Int 91:244–249

    Article  CAS  PubMed  Google Scholar 

  6. Puhaindran ME, Farooki A, Steensma MR, Hameed M, Healey JH, Boland PJ (2011) Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates. J Bone Joint Surg Am 93:1235–1242

    Article  PubMed  Google Scholar 

  7. Thompson RN, Phillips JR, McCauley SH, Elliott JR, Moran CG (2012) Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals. J Bone Joint Surg (Br) 94:385–390

    Article  CAS  Google Scholar 

  8. Jorgensen NR, Schwarz P (2011) Effects of anti-osteoporosis medications on fracture healing. Curr Osteoporos Rep 9:149–155

    Article  PubMed  Google Scholar 

  9. Savaridas T, Wallace RJ, Salter DM, Simpson AH (2013) Do bisphosphonates inhibit direct fracture healing?: A laboratory investigation using an animal model. Bone Joint J 95-B:1263–1268

    Article  CAS  PubMed  Google Scholar 

  10. Goodship AE, Walker PC, McNally D, Chambers T, Green JR (1994) Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone. Ann Oncol 5(Suppl 7):S53–S55

    PubMed  Google Scholar 

  11. Colon-Emeric C, Nordsletten L, Olson S, Major N, Boonen S et al (2011) Association between timing of zoledronic acid infusion and hip fracture healing. Osteoporos Int 22:2329–2336

    Article  CAS  PubMed  Google Scholar 

  12. Gong HS, Song CH, Lee YH, Rhee SH, Lee HJ, Baek GH (2012) Early initiation of bisphosphonate does not affect healing and outcomes of volar plate fixation of osteoporotic distal radial fractures. J Bone Joint Surg Am 94:1729–1736

    Article  PubMed  Google Scholar 

  13. Xue D, Li F, Chen G, Yan S, Pan Z (2014) Do bisphosphonates affect bone healing? A meta-analysis of randomized controlled trials. J Orthop Surg Res 9:45

    Article  PubMed Central  PubMed  Google Scholar 

  14. Ha KY, Kim YH (2013) Risk factors affecting progressive collapse of acute osteoporotic spinal fractures. Osteoporos Int 24:1207–1213

    Article  CAS  PubMed  Google Scholar 

  15. Choi YJ, Oh HJ, Kim DJ, Lee Y, Chung YS (2012) The prevalence of osteoporosis in Korean adults aged 50 years or older and the higher diagnosis rates in women who were beneficiaries of a national screening program: the Korea National Health and Nutrition Examination Survey 2008-2009. J Bone Miner Res 27:1879–1886

    Article  PubMed  Google Scholar 

  16. Lange A, Zeidler J, Braun S (2014) One-year disease-related health care costs of incident vertebral fractures in osteoporotic patients. Osteoporos Int 25:2435–2443

    Article  CAS  PubMed  Google Scholar 

  17. Ha KY, Kim YH, Chang DG, Son IN, Kim KW, Kim SE (2013) Causes of late revision surgery after bone cement augmentation in osteoporotic vertebral compression fractures. Asian Spine J 7:294–300

    Article  PubMed Central  PubMed  Google Scholar 

  18. Sudo H, Ito M, Abumi K, Kotani Y, Takahata M, Hojo Y, Minami A (2010) One-stage posterior instrumentation surgery for the treatment of osteoporotic vertebral collapse with neurological deficits. Eur Spine J 19:907–915

    Article  PubMed Central  PubMed  Google Scholar 

  19. Kim YC, Kim YH, Ha KY (2014) Pathomechanism of intravertebral clefts in osteoporotic compression fractures of the spine. Spine J 14:659–666

    Article  PubMed  Google Scholar 

  20. Tsujio T, Nakamura H, Terai H, Hoshino M, Namikawa T, Matsumura A, Kato M, Suzuki A, Takayama K, Fukushima W, Kondo K, Hirota Y, Takaoka K (2011) Characteristic radiographic or magnetic resonance images of fresh osteoporotic vertebral fractures predicting potential risk for nonunion: a prospective multicenter study. Spine (Phila Pa 1976) 36:1229–1235

    Article  Google Scholar 

  21. Ito M, Harada A, Nakano T, Kuratsu S, Deguchi M, Sueyoshi Y, Machida M, Yonezawa Y, Matsuyama Y, Wakao N (2010) Retrospective multicenter study of surgical treatments for osteoporotic vertebral fractures. J Orthop Sci 15:289–293

    Article  PubMed  Google Scholar 

  22. Hashidate H, Kamimura M, Nakagawa H, Takahara K, Uchiyama S (2006) Pseudoarthrosis of vertebral fracture: radiographic and characteristic clinical features and natural history. J Orthop Sci 11:28–33

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

None.

Funding sources

This study was partially supported by a grant from Catholic Institute of Cell therapy in 2014.

Ethical issues

Approval of institutional review board was obtained before enrollment of the patients (approval No. KC13OISI0492).

Author information

Authors and Affiliations

  1. Department of Orthopedic Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-Daero, Seocho-Gu, Seoul, 137-701, Republic of Korea

    K.-Y. Ha, K.-S. Park, S.-I. Kim & Y.-H. Kim

Authors
  1. K.-Y. Ha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K.-S. Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S.-I. Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y.-H. Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y.-H. Kim.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ha, KY., Park, KS., Kim, SI. et al. Does bisphosphonate-based anti-osteoporosis medication affect osteoporotic spinal fracture healing?. Osteoporos Int 27, 483–488 (2016). https://doi.org/10.1007/s00198-015-3243-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-015-3243-6

Keywords

Search

Navigation